<?xml version='1.0' encoding='utf-8'?>
<?xml-stylesheet type="text/xsl" href="/v2/static/oai2.xsl"?>
<OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd">
  <responseDate>2026-10-11T11:30:56Z</responseDate>
  <request identifier="oai:figshare.com:article/33957887" metadataPrefix="oai_dc" verb="GetRecord">https://api.figshare.com/v2/oai</request>
  <GetRecord>
    <record>
      <header>
        <identifier>oai:figshare.com:article/33957887</identifier>
        <datestamp>2026-09-21T17:50:05Z</datestamp>
        <setSpec>category_16</setSpec>
        <setSpec>category_19</setSpec>
        <setSpec>category_39</setSpec>
        <setSpec>category_46</setSpec>
        <setSpec>category_734</setSpec>
        <setSpec>category_931</setSpec>
        <setSpec>category_61</setSpec>
        <setSpec>category_64</setSpec>
        <setSpec>category_128</setSpec>
        <setSpec>category_132</setSpec>
        <setSpec>portal_5</setSpec>
        <setSpec>item_type_3</setSpec>
        <setSpec>month_year_09_2026</setSpec>
      </header>
      <metadata>
        <oai_dc:dc xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"  xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:dc="http://purl.org/dc/elements/1.1/" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
          <dc:title>&lt;p&gt;Ranking of scenarios according to the AIC-inspired criterion (23), with  mg/mL. Lower IC values indicate a better trade-off between goodness of fit and model complexity.&lt;/p&gt;</dc:title>
          <dc:creator>Sara Sottile (25084865)</dc:creator>
          <dc:creator>Conception Paul (25084868)</dc:creator>
          <dc:creator>Rachel Audo (96127)</dc:creator>
          <dc:creator>Theo Rispens (216183)</dc:creator>
          <dc:creator>Denis Mulleman (9439112)</dc:creator>
          <dc:creator>Peter Rashkov (3368651)</dc:creator>
          <dc:subject>Physiology</dc:subject>
          <dc:subject>Pharmacology</dc:subject>
          <dc:subject>Ecology</dc:subject>
          <dc:subject>Immunology</dc:subject>
          <dc:subject>Biological Sciences not elsewhere classified</dc:subject>
          <dc:subject>Information Systems not elsewhere classified</dc:subject>
          <dc:subject>Developmental Biology</dc:subject>
          <dc:subject>Cancer</dc:subject>
          <dc:subject>Hematology</dc:subject>
          <dc:subject>Infectious Diseases</dc:subject>
          <dc:subject>treat severe cases</dc:subject>
          <dc:subject>simulate immunogenic responses</dc:subject>
          <dc:subject>patients discontinue due</dc:subject>
          <dc:subject>ordinary differential equations</dc:subject>
          <dc:subject>involved 110 patients</dc:subject>
          <dc:subject>mathematical models established</dc:subject>
          <dc:subject>immune cell subsets</dc:subject>
          <dc:subject>b lymphocytes ),</dc:subject>
          <dc:subject>div &gt;&lt; p</dc:subject>
          <dc:subject>methotrexate &amp;# 8217</dc:subject>
          <dc:subject>received adalimumab alone</dc:subject>
          <dc:subject>ineffective alone</dc:subject>
          <dc:subject>mathematical model</dc:subject>
          <dc:subject>methotrexate ),</dc:subject>
          <dc:subject>vitro experiments</dc:subject>
          <dc:subject>therapeutic compounds</dc:subject>
          <dc:subject>therapeutic compound</dc:subject>
          <dc:subject>temporal dynamics</dc:subject>
          <dc:subject>shown potential</dc:subject>
          <dc:subject>reduced effectiveness</dc:subject>
          <dc:subject>previously published</dc:subject>
          <dc:subject>original data</dc:subject>
          <dc:subject>lymphocyte counts</dc:subject>
          <dc:subject>increasing apoptosis</dc:subject>
          <dc:subject>immune cells</dc:subject>
          <dc:subject>drug antibodies</dc:subject>
          <dc:subject>clinical trial</dc:subject>
          <dc:subject>axial spondyloarthritis</dc:subject>
          <dc:description>&lt;p&gt;Ranking of scenarios according to the AIC-inspired criterion (23), with  mg/mL. Lower IC values indicate a better trade-off between goodness of fit and model complexity.&lt;/p&gt;</dc:description>
          <dc:date>2026-09-21T17:49:43Z</dc:date>
          <dc:type>Dataset</dc:type>
          <dc:type>Dataset</dc:type>
          <dc:identifier>10.1371/journal.pcbi.1014740.t004</dc:identifier>
          <dc:relation>https://figshare.com/articles/dataset/_p_Ranking_of_scenarios_according_to_the_AIC-inspired_criterion_23_with_mg_mL_Lower_IC_values_indicate_a_better_trade-off_between_goodness_of_fit_and_model_complexity_p_/33957887</dc:relation>
          <dc:rights>CC BY 4.0</dc:rights>
        </oai_dc:dc>
      </metadata>
    </record>
  </GetRecord>
</OAI-PMH>
